AI Insights · Timothy · July 2023
Top 5 Health and Fitness Apps on iOS in Algeria, Q2 2023
In Q2 2023, the top health and fitness apps on iOS in Algeria saw varied performance, with notable trends in weekly downloads, revenue, and active users. Data from Sensor Tower reveals key insights into these apps' market presence.
The second quarter of 2023 highlighted the dynamic performance of the top health and fitness apps on iOS in Algeria. Here's a detailed look at the trends observed in iFIT At-Home Workout & Fitness, MyFitnessPal: Calorie Counter, FaceYogi® - Face Yoga Exercise, Flo Period & Pregnancy Tracker, and Heartify: Heart Health Monitor.
iFIT At-Home Workout & Fitness had a mixed performance with revenue peaking at around $243 in the week of June 19. Downloads remained minimal, with a notable occurrence of 2 downloads in the week of May 15.
For MyFitnessPal: Calorie Counter, the app saw a significant peak in weekly revenue, reaching $158 in mid-June. Downloads showed a consistent trend, peaking at 651 in the last week of May. Active users remained stable, fluctuating between 7.9K and 8.6K throughout the quarter.
FaceYogi® - Face Yoga Exercise demonstrated steady revenue, consistently around the $40 mark, with the highest at $55 in early April. Downloads peaked at 76 in the week of April 3, while active users saw a slight decline from 6.5K to 5.9K by the end of June.
Flo Period & Pregnancy Tracker experienced varying revenue, with the highest weekly revenue of $107 in mid-June. Downloads were consistent, peaking at 962 in the last week of March. Active users showed a slight decline, ending the quarter with 12K from a high of 14.3K.
Heartify: Heart Health Monitor saw stable revenue, peaking at $53 in late May. Downloads were highest at 175 in mid-June. Active users increased steadily, reaching 2.1K by the end of June.
These insights, provided by Sensor Tower, offer a comprehensive look at the performance of these top health and fitness apps in Algeria. For more detailed analytics and trends, visit Sensor Tower.